A novel curcumin-loaded nanoparticle restricts atherosclerosis development and promotes plaques stability in apolipoprotein E deficient mice

Abstract

Although curcumin possesses anti-atherogenic and anti-inflammatory properties, its application is limited because of its low aqueous solubility and poor oral bioavailability. Recently, our group synthesized a novel linear-dendrimer methoxy-poly (ethylene glycol)-b-poly(ε-caprolactone) copolymer nanoparticle loading curcumin (Cur-NPs) which could improve solubility and release property of curcumin. In the present study, we further evaluated its anti-atherosclerotic effect in apolipoprotein E^−/− mice. Our results demonstrated that the Cur-NPs significantly decreased atherosclerotic lesion areas and were more effective in stabilizing vulnerable plaques compared with free curcumin. The anti-atherosclerotic mechanisms of Cur-NPs include decreasing the number of introplaque microvessels, inhibiting the matrix metalloproteinase 2 and 9 activity, reducing the inflammatory response and regulating lipoprotein cholesterol metabolism more effectively compared with free curcumin. Furthermore, Cur-NPs could increase the amount of curcumin in the thoracic aorta and no significant toxicity was observed in the blood biochemical parameters in Cur-NPs-treated groups. Overall, our findings suggested that Cur-NPs could be a stabilized aqueous formulation for application with improved curcumin activity, which could be a potential treatment strategy for arteriosclerosis in the future.

Keywords

Curcumin nanoparticle arteriosclerosis plaques stability

Get full access to this article

View all access options for this article.

References

Orekhov

Sobenin

Revin

et al . Development of antiatherosclerotic drugs on the basis of natural products using cell model approach. Oxid Med Cell Longev 2015; 2015: 463797.

Shin

McGregor

et al . Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol Nutr Food Res 2011; 55: 1829–1840.

Hwang

Choi

et al . Curcumin attenuates adhesion molecules and matrix metalloproteinase expression in hypercholesterolemic rabbits. Nutr Res 2014; 34: 886–893.

Wan

Liu

Yang

et al . Effect of curcumin on inhibiting atherogenesis by down-regulating lipocalin-2 expression in apolipoprotein E knockout mice. Biomed Mater Eng 2016; 27: 577–587.

Coban

Milenkovic

Chanet

et al . Dietary curcumin inhibits atherosclerosis by affecting the expression of genes involved in leukocyte adhesion and transendothelial migration. Mol Nutr Food Res 2012; 56: 1270–1281.

Zhang

Zou

et al . Curcumin protects against atherosclerosis in apolipoprotein E-knockout mice by inhibiting toll-like receptor 4 expression. J Agric Food Chem 2018; 66: 449–456.

Shome

Talukdar

Choudhury

et al . Curcumin as potential therapeutic natural product: a nanobiotechnological perspective. J Pharm Pharmacol 2016; 68: 1481–1500.

Gera

Sharma

Ghosh

et al . Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget 2017; 8: 66680–66698.

Matoba

Koga

Nakano

et al . Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease. J Cardiol 2017; 70: 206–211.

10.

Song

Zhu

Song

et al . Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (epsilon-caprolactone) copolymer micelles for the delivery of curcumin. Drug Deliv 2015; 22: 58–68.

11.

Kilkenny

Browne

Cuthill

et al . Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412.

12.

Andres-Manzano

Andres

Dorado

Oil red O and hematoxylin and eosin staining for quantification of atherosclerosis burden in mouse aorta and aortic root. Methods Mol Biol 2015; 1339: 85–99.

13.

Mohanty

Sahoo

SK.

The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 2010; 31: 6597–6611.

14.

Sherin

Sheeja

Sudha Devi

et al . In vitro and in vivo pharmacokinetics and toxicity evaluation of curcumin incorporated titanium dioxide nanoparticles for biomedical applications. Chem Biol Interact 2017; 275: 35–46.

15.

Jawien

The role of an experimental model of atherosclerosis: apoE-knockout mice in developing new drugs against atherogenesis. Curr Pharm Biotechnol 2012; 13: 2435–2439.

16.

Camare

Pucelle

Negre-Salvayre

et al . Angiogenesis in the atherosclerotic plaque. Redox Biol 2017; 12: 18–34.

17.

Hakimzadeh

Pinas

Molenaar

et al . Novel molecular imaging ligands targeting matrix metalloproteinases 2 and 9 for imaging of unstable atherosclerotic plaques. PLoS One 2017; 12: e0187767

18.

Centurion

OA.

Serum biomarkers and source of inflammation in acute coronary syndromes and percutaneous coronary interventions. Cardiovasc Revasc Med 2016; 17: 119–128.

19.

Miteva

Madonna

De Caterina

et al. Innate and adaptive immunity in atherosclerosis. Vascul Pharmacol 2018; 107: 66–77.

20.

Matoba

Sato

Egashira

Mouse models of plaque rupture. Curr Opin Lipidol 2013; 24: 419–425.

21.

Van der Veken

De Meyer

Martinet

Intraplaque neovascularization as a novel therapeutic target in advanced atherosclerosis. Expert Opin Ther Targets 2016; 20: 1247–1257.

22.

Hasan

Zingg

Kwan

et al . Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Atherosclerosis 2014; 232: 40–51.

23.

Panahi

Ahmadi

Teymouri

et al . Curcumin as a potential candidate for treating hyperlipidemia: a review of cellular and metabolic mechanisms. J Cell Physiol 2018; 233: 141–152.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.18 MB